Antiviral Therapeutic Potential of Curcumin: An Update.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
19 Nov 2021
Historique:
received: 30 09 2021
revised: 15 11 2021
accepted: 16 11 2021
entrez: 27 11 2021
pubmed: 28 11 2021
medline: 15 12 2021
Statut: epublish

Résumé

The treatment of viral disease has become a medical challenge because of the increasing incidence and prevalence of human viral pathogens, as well as the lack of viable treatment alternatives, including plant-derived strategies. This review attempts to investigate the trends of research on in vitro antiviral effects of curcumin against different classes of human viral pathogens worldwide. Various electronic databases, including PubMed, Scopus, Web of Science, and Google Scholar were searched for published English articles evaluating the anti-viral activity of curcumin. Data were then extracted and analyzed. The forty-three studies (published from 1993 to 2020) that were identified contain data for 24 different viruses. The 50% cytotoxic concentration (CC50), 50% effective/inhibitory concentration (EC50/IC50), and stimulation index (SI) parameters showed that curcumin had antiviral activity against viruses causing diseases in humans. Data presented in this review highlight the potential antiviral applications of curcumin and open new avenues for further experiments on the clinical applications of curcumin and its derivatives.

Identifiants

pubmed: 34834089
pii: molecules26226994
doi: 10.3390/molecules26226994
pmc: PMC8617637
pii:
doi:

Substances chimiques

Antiviral Agents 0
Curcumin IT942ZTH98

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Res Virol. 1998 Jan-Feb;149(1):43-52
pubmed: 9561563
Environ Toxicol Pharmacol. 2014 May;37(3):1140-7
pubmed: 24802527
Antiviral Res. 2019 Jul;167:98-103
pubmed: 31034848
Virology. 2021 Oct;562:63-73
pubmed: 34265628
Biomed Res Int. 2021 Aug 9;2021:1807293
pubmed: 34409100
J Cell Physiol. 2011 Dec;226(12):3385-91
pubmed: 21344388
Clin Infect Dis. 2000 Jun;30 Suppl 2:S171-6
pubmed: 10860902
Br J Pharmacol. 2013 Mar;168(5):1059-73
pubmed: 23072320
Drug Des Devel Ther. 2015 Sep 03;9:5051-60
pubmed: 26366056
Antiviral Res. 2017 Jun;142:148-157
pubmed: 28343845
Photodiagnosis Photodyn Ther. 2015 Sep;12(3):385-92
pubmed: 26117199
Lancet. 2003 Dec 13;362(9400):2002-11
pubmed: 14683662
PLoS One. 2013 Sep 18;8(9):e70225
pubmed: 24058438
BMC Gastroenterol. 2019 Jun 20;19(1):100
pubmed: 31221096
Immunol Invest. 2017 Nov;46(8):833-846
pubmed: 29058549
Phytother Res. 2020 Nov;34(11):2911-2920
pubmed: 32430996
PLoS One. 2013 May 01;8(5):e62482
pubmed: 23658730
PLoS One. 2018 Jan 25;13(1):e0191617
pubmed: 29370243
Acta Virol. 2018;62(4):394-400
pubmed: 30472869
Sci Rep. 2016 Jun 10;6:27539
pubmed: 27283735
Int J Mol Sci. 2020 Jan 04;21(1):
pubmed: 31947962
FEBS Lett. 2010 Jun 3;584(11):2485-90
pubmed: 20434445
Antiviral Res. 2008 Jan;77(1):1-5
pubmed: 17765333
Antiviral Res. 2016 Jan;125:51-7
pubmed: 26611396
PLoS One. 2016 Oct 27;11(10):e0165386
pubmed: 27788205
Futur J Pharm Sci. 2020;6(1):104
pubmed: 33215042
Cancer Surv. 1986;5(2):367-87
pubmed: 2946406
BMJ. 2005 Jul 2;331(7507):10
pubmed: 15994677
Sci Rep. 2021 Sep 27;11(1):19125
pubmed: 34580340
Fish Shellfish Immunol. 2015 Jul;45(1):184-93
pubmed: 25862970
Viruses. 2019 Nov 02;11(11):
pubmed: 31684080
Microorganisms. 2020 Oct 04;8(10):
pubmed: 33020422
Biochem Pharmacol. 1995 Apr 18;49(8):1165-70
pubmed: 7748198
J Gen Virol. 2020 Oct;101(10):1079-1084
pubmed: 32677610
Pharm Nanotechnol. 2020;8(1):54-62
pubmed: 31858909
J Virol. 2007 Apr;81(7):3142-50
pubmed: 17229707
Molecules. 2016 Oct 20;21(10):
pubmed: 27775614
PLoS One. 2015 Apr 09;10(4):e0124903
pubmed: 25856395
Front Microbiol. 2019 May 03;10:912
pubmed: 31130924
Antimicrob Agents Chemother. 2007 May;51(5):1859-62
pubmed: 17353250
Food Environ Virol. 2016 Dec;8(4):244-250
pubmed: 27496054
Front Vet Sci. 2019 Feb 20;6:38
pubmed: 30842948
Acta Pharm Sin B. 2014 Aug;4(4):284-94
pubmed: 26579397
Gut. 2014 Jul;63(7):1137-49
pubmed: 23903236
Virology. 2008 Apr 10;373(2):239-47
pubmed: 18191976
Biochemistry. 2007 Sep 11;46(36):10384-91
pubmed: 17705403
Biomed Res Int. 2014;2014:186864
pubmed: 24877064
J Ethnopharmacol. 2009 Jul 15;124(2):189-96
pubmed: 19409970
BMC Complement Altern Med. 2014 Aug 04;14:284
pubmed: 25088288
Acta Virol. 2015 Sep;59(3):221-7
pubmed: 26435144
J Cardiovasc Pharmacol Ther. 2013 Nov;18(6):560-9
pubmed: 24057864
FEBS Lett. 2010 Feb 19;584(4):707-12
pubmed: 20026048
J Cell Biochem. 2019 Sep;120(9):15740-15745
pubmed: 31074052
Virusdisease. 2020 Jun;31(2):179-193
pubmed: 32656311
J Gen Virol. 2004 Aug;85(Pt 8):2347-2356
pubmed: 15269376
Arch Pharm Res. 2020 May;43(5):489-502
pubmed: 32248350
Int J Mol Med. 2012 Nov;30(5):1021-8
pubmed: 22922731
Phytomedicine. 2021 May;85:153317
pubmed: 32943302
Antiviral Res. 2019 Feb;162:71-78
pubmed: 30529358
World J Gastroenterol. 2017 Sep 14;23(34):6252-6260
pubmed: 28974891
Colloids Surf B Biointerfaces. 2019 Aug 1;180:289-297
pubmed: 31071568
Leuk Res. 2006 Mar;30(3):313-21
pubmed: 16157375
J Neuroimmune Pharmacol. 2009 Sep;4(3):328-37
pubmed: 19434500
J Biol Chem. 2012 Sep 28;287(40):33198-214
pubmed: 22847000
Nat Prod Commun. 2010 Dec;5(12):1935-8
pubmed: 21299124

Auteurs

Abdollah Ardebili (A)

Laboratory Sciences Research Center, Golestan University of Medical Sciences, Gorgan 4934174515, Iran.
Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan 4934174515, Iran.

Mohammad Hassan Pouriayevali (MH)

Department of Arboviruses and Viral Hemorrhagic Fevers (National Ref Lab), Pasteur Institute of Iran, Tehran 1316943551, Iran.

Sahar Aleshikh (S)

Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan 4934174515, Iran.

Marziyeh Zahani (M)

Student Research Committee, Faculty of Paramedicine, Golestan University of Medical Sciences, Gorgan 4934174515, Iran.

Mehdi Ajorloo (M)

Hepatitis Research Center, Lorestan University of Medical Sciences, Khorramabad 6813833946, Iran.
Department of Virology, Lorestan University of Medical Sciences, Khorramabad 6813833946, Iran.

Ahdieh Izanloo (A)

Department of Biology, Faculty of Science, Golestan University, Gorgan 4934174515, Iran.

Abolghasem Siyadatpanah (A)

Ferdows School of Paramedical and Health, Birjand University of Medical Sciences, Birjand 9717853577, Iran.

Hadi Razavi Nikoo (H)

Department of Microbiology, Faculty of Medicine, Golestan University of Medical Sciences, Gorgan 4934174515, Iran.
Infectious Diseases Research Center, Golestan University of Medical Sciences, Gorgan 4934174515, Iran.

Polrat Wilairatana (P)

Department of Clinical Tropical Medicine, Faculty of Tropical Medicine, Mahidol University, Bangkok 10400, Thailand.

Henrique Douglas Melo Coutinho (HDM)

Laboratory of Microbiology and Molecular Biology (LMBM), Regional University of Cariri (URCA), Crato 63105-000, CE, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH